Liven Pharma Limited (PSX:LIVEN)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
31.48
-0.42 (-1.32%)
At close: Oct 19, 2026

Liven Pharma Financials Overview

Millions PKR. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
105.81105.81127.27245.09--
Revenue Growth
-16.87%-16.87%-48.07%---
Gross Profit
-10.73-10.7315.8262.14--
Operating Income
-75.93-75.93-491.7141.77-15.22-17.51
Net Income
-31.14-31.14-584.4641.74-12.33-14.29
Earnings Per Share
-0.28-0.28-7.111043.60-1.02-1.18
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
181.55181.557.8824.960.030.03
Total Debt
33.4433.4434.67156.91237.62235.35
Net Cash (Debt)
148.11148.11-26.78-131.95-237.59-235.32
Net Cash Growth
------
Net Cash Per Share
1.331.33-0.33-3298.85-19.60-19.41

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
8.998.99-1.7213.8-2.27-2.26
Capital Expenditures
-29.66-29.66-22.84---
Free Cash Flow
-20.68-20.68-24.5613.8-2.27-2.26
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
-10.14%-10.14%12.43%25.35%--
Operating Margin
-71.76%-71.76%-386.34%17.04%--
Pretax Margin
-62.68%-62.68%-386.72%17.03%--
Profit Margin
-29.43%-29.43%-459.22%17.03%--
FCF Margin
-19.54%-19.54%-19.30%5.63%--

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingOct '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PE Ratio
---2.65--
P/FCF Ratio
---8.00--
PS Ratio
33.9643.5047.470.45--